Introduction
Mucinous cystic neoplasms (MCNs) of the pancreas are relatively rare cystic neoplasms that usually arise in the body or tail of the pancreas. More than 90% arise in females (Thompson et al., 1999; Zamboni et al., 1999) . Pancreatic MCNs were first distinguished from serous cystic neoplasms by Compagno and Oertel (1978) . Subsequently, all mucin-producing cystic neoplasms were considered to be MCNs until 1982 when Ohhashi et al. (1982) recognized the unique features of intraductal papillary-mucinous neoplasms (IPMNs). MCNs consist of a neoplastic mucin-secreting columnar epithelium and are usually accompanied by a characteristic highly cellular stroma with spindle cells resembling ovarian stroma (Fukushima and Mukai, 1997; Zamboni et al., 1999) . The distinctive nature of 'ovarian-type' stroma is valuable for diagnosing MCNs especially in cases in which the neoplastic epithelium is denuded from the cyst. Without the presence of an 'ovarian-type' stroma, MCNs can be difficult to distinguish from IPMNs, which are also mucin-producing epithelial neoplasms but which lack a distinct stroma.
Cystic neoplasms represent only a small minority of pancreatic cyst lesions (Solcia et al., 1997; Fukushima and Mukai, 1999; Demos et al., 2002) . Most pancreatic cysts are pseudocysts, which contain an inflammatory and fibrotic tissue wall without an epithelial lining. With improvements in diagnostic imaging, cystic pancreatic lesions are becoming increasingly recognized. The distinction between non-neoplastic pseudocysts and cystic neoplasms is critical, because some cystic neoplasms progress to invasive cancer. Unfortunately, cystic neoplasms are clinically often misdiagnosed as pseudocysts, which leads to delayed diagnosis and failed opportunities for curative resection (Warshaw et al., 1990; Demos et al., 2002) . Molecular markers that could accurately identify neoplastic cystic lesions could help improve the management of patients with cystic lesions. In addition, better knowledge of the molecular alterations that give rise to MCNs could help in the management of patients with these neoplasms. Because MCNs are uncommon and usually only contain a small number of neoplastic cells, molecular studies are difficult and as a result information about these neoplasms has largely been derived from immunohistochemical studies of proteins such as p53 (Thompson et al., 1999; Zamboni et al., 1999; Yoshizawa et al., 2002) , mucin proteins (Luttges et al., 2002) , markers of gastric or intestinal differentiation (Zamboni et al., 1999) , as well as protein expression patterns within the 'ovarian-type' stroma (Fukushima and Mukai, 1997; Izumo et al., 2003) . In contrast, much more is known about the genetic and epigenetic alterations involved in the development of pancreatic ductal adenocarcinomas, IPMNs and pancreatic intraepithelial neoplasms (PanINs). For example, pancreatic ductal adenocarcinomas can harbor genetic alterations of a large number of genes including K-ras, p53, p16, SMAD4, BRCA2, MKK4, hMLH1, TGFBR2, TGFBR1, STK11, FANCC, FANCG, ALK4 and BRAF genes Klein et al., 2001; Su et al., 2001; Kern et al., 2002; van der Heijden et al., 2003) , as well as numerous alterations in DNA methylation (Ueki et al., 2000 Sato et al., 2003a, b) . Several similar genetic and/or epigenetic abnormalities have also been described in IPMNs including alteration of the K-ras, p53 and STK11/LKB1 genes (Sessa et al., 1994; Sato et al., 2001 Sato et al., , 2002 . Global gene expression profiles of pancreatic ductal adenocarcinomas and of IPMNs have provided information about candidate molecular markers of these neoplasms as well as providing information as to their tumor biology (Ryu et al., 2001 (Ryu et al., , 2002 Iacobuzio-Donahue et al., 2002 Terris et al., 2002; Logsdon et al., 2003; Sato et al., 2004) .
To better understand the biology of MCNs and to identify candidate diagnostic markers, we performed global gene expression profiling of neoplastic epithelial and 'ovarian-type' stromal cell components of MCNs using high-density oligomicroarrays and laser capture microdissection (LCM).
Results

Identification of genes overexpressed in the neoplastic epithelium of MCNs
Sufficient neoplastic epithelial cells for microarray analysis were obtained from six of the eight MCNs, including three adenomas (two flat and one low papillary lesion), two borderline (a flat and a papillary lesion) and one non-invasive mucinous cystic adenocarcinoma (a papillary lesion) ( Table 1) .
The cell that gives rise to MCNs has not been established. Therefore, in order to identify genes overexpressed in MCNs relative to their normal pancreatic cell counterpart, we first analysed the gene expression profiles of MCNs to determine if they could indicate its cell of origin. We probed the Affymetrix gene expression profiles of normal and neoplastic pancreatic tissues for a list of genes that are known for their pancreatic ductal or acinar expression (Table 2) . Genes expressed in normal pancreatic ductal epithelium with little expression in pancreatic acini, such as Keratin 19, Trefoil factor 1 (TFF1) and Trefoil factor 2 (TFF2), were also highly expressed in MCNs (Table 3) . In contrast, acinar-specific genes such as elastase and trypsin were absent or underexpressed in MCNs. Several acinar-specific genes were also detected in the microdissected pancreatic duct samples, suggesting some acinar cell contamination in these microdissections. Indeed, despite the use of the laser capture microscope for microdissections, small amounts of acinar tissue were lifted onto the cap during dissection (Table 3) . Overall, these data suggested that the neoplastic epithelium of MCNs is of ductal origin (Figure 1) .
We therefore compared the gene expression profiles of MCNs to that of normal-appearing pancreatic ductal epithelium. A total of 206 gene fragments were identified as overexpressed at least threefold in the epithelial neoplastic component of the MCNs (n ¼ 6) compared to normal pancreatic ductal epithelium (n ¼ 5). Of these Table 5 . Some notable genes in this list included sex hormone-related genes (steroidogenic acute regulatory protein, STAR, increased 71.1-fold; estrogen receptor 1, ESR1, increased 7.3-fold), genes involved in cell proliferation (wingless-type MMTV integration site family, member 2B, WNT2B, increased 8.0-fold; sFRP 1, increased 7.1-fold; fibroblast growth factor 2, increased 6.6-fold), smooth musclerelated genes (actin binding LIM protein 1, increased 5.9-fold; actin alpha 2, increased 5.4-fold; myosin, heavy polypeptide 11, smooth muscle, increased 5.6-fold), genes expressed in the extracellular matrix (osteoglycin, increased 12.1-fold) and several neuronal cell-related genes (cell adhesion molecule L1CAM, increased 15.1-fold; neuroepithelial cell transforming gene 1, increased 7.2-fold; brain-derived neurotrophic factor, increased 5.8-fold; neuronal cell adhesion molecule NRCAM, increased 5.0-fold).
Confirmation of expression of selected genes using quantitative RT-PCR
To confirm the expression patterns of genes identified as overexpressed by microarray, we employed quantitative RT-PCR. We examined the expression levels of five genes identified as overexpressed in the neoplastic epithelium of MCNs compared to normal pancreatic duct by microarray (S100P, PSCA, Jagged1, HEC and c-myc), and five genes (STAR, ESR1, L1CAM, WNT2B and SFRP1) identified as overexpressed in the ovariantype stroma compared to microdissected fibrous stroma Relative value compared to the signal intensity of normal appearing ducts or acini (Figures 2 and 3) . The mean expression levels of S100P, PSCA, Jagged1, HEC and c-myc in neoplastic epithelial samples were increased 21.3-, 4.04-, 1.8-, 4.9-and 4.9-fold compared to those in normal ductal epithelial samples, respectively. Generally, gene expression levels were higher in lesions of higher histological grade (borderline and carcinoma in situ).
The mean expression levels of STAR, ESR1, L1CAM, WNT2B and SFRP1 in 'ovarian-type' stromal samples were increased 65.6-, 26.5-, 16.1-, 1.8-and 5.0-fold compared to the fibrous stromal tissue samples, respectively. Interestingly, the expression levels of four out of the five above-described genes in cultured fibroblast cells were decreased compared to microdissected fibrous tissue samples from surgically resected specimens.
Immunohistochemical analysis
To evaluate whether the transcripts identified by oligonucleotide microarray analysis were overexpressed at the protein level, we performed immunohistochemistry on tissue microarrays (TMAs) using commercially available antibodies for four proteins (Jagged, PSCA, Frizzled and L1CAM), whose transcripts were overexpressed in either the epithelium or stroma of MCNs by oligonucleotide microarray analysis. We also evaluated the expression of HES1, a downstream member of the Notch pathway, on frozen section slides of six MCNs to further evaluate the significance of overexpression of Jagged1 and Dlk in the epithelia of MCNs. In all, 57 of the 76 TMA cores of MCNs were evaluable by immunohistochemistry. We evaluated cores from 23 epithelial lesions (13 adenomas, five borderline MCNs and five mucinous cystic adenocarcinomas) and cores from 14 areas of 'ovarian-type' stroma (cores from the same neoplasm of the same grade were counted as one lesion). Five of the 19 MCN neoplasms contained regions of tumor of more than one grade. Jagged1 protein expression was evident in both the cytoplasm and nuclei of the neoplastic cells with less intense expression in normal-appearing pancreatic ductal epithelium, in acinar cells and in islet cells. Seven of 15 cores of ovarian-type stroma had weak nuclear expression of Jagged1. Overall, 30.4% (7/23) of all the MCNs expressed Jagged by immunohistochemistry. Intense and prevalent nuclear staining of HES1 protein was observed in both borderline and carcinoma in situ neoplasms (MCN-5 and -6) ( Figure 4c ). Those two neoplasms showed marked papillary growth. No staining in the stromal cells was observed. PSCA protein expression was seen in 34.8% (8/23) of MCNs with expression localized to the cytoplasm of the neoplastic cells (Figure 4b and d) . Expression was more likely in high-grade MCNs than in low-grade MCNs, although this difference did not reach statistical significance; Jagged1 expression was seen in 50% of high-grade and 15.4% of low-grade lesions. PSCA was expressed in 50% of high-grade and 23.1% of low-grade lesions. Four of the 14 'ovarian-type' stroma tissues labeled intensely with the anti-Frizzled antibody, and four other lesions were weakly positive for Frizzled. L1CAM protein was strongly expressed in peripheral nerve tissues. Two of 14 'ovarian-type' stroma showed cytoplasmic and fine meshes of net-like membranous staining (Figure 4f) . In contrast to the labeling Figure 2 Quantitative RT-PCR analysis of five genes in neoplastic epithelium of the MCNs. The fold change levels on the vertical axis are relative to the expression in normal ductal cell samples (n ¼ 5) Figure 3 Quantitative RT-PCR analysis of five genes in 'ovariantype' stroma of the MCNs. Solid bars and dot-blot bars represent a fold change levels of gene expression in 'ovarian-type' stroma (n ¼ 4) and in cultured fibroblastic cells (n ¼ 1) compared to that of microdissected fibrous stromal cells in chronic pancreatitis (n ¼ 3)
Gene expression profile in MCNs N Fukushima et al of stroma fibroblasts, the lining neoplastic epithelium did not label.
Discussion
In this study, we used high-density oligonucleotide microarrays, LCM and liner RNA amplification to identify genes overexpressed in MCNs. Several of the genes identified as overexpressed are likely to contribute to the biological features of MCNs and may also have diagnostic potential as molecular markers. MCNs are a relatively uncommon neoplasm compared to usual pancreatic cancers and relatively few frozen specimens of MCNs of the pancreas are available for research studies. For this reason and to confirm our gene expression results, we performed immunohistochemical analysis of candidate overexpressed genes in a larger independent series of MCNs.
Among the genes we identified as overexpressed in the neoplastic epithelium of MCNs were several members of the Notch pathway including Jagged1 and dlk. In addition, since the HES1 gene fragment was not contained on the U133A gene chip, we performed Hes1 immunohistochemistry, which demonstrated intense nuclear expression of HES1 protein in high-grade MCNs. The Notch signaling pathway has been reported to play an essential role in cellular specification, proliferation and differentiation in a wide variety of developmental processes including pancreatic differentiation (Apelqvist et al., 1999; Maillard and Pear, 2003) . Aberrant Notch signaling has also been observed in several human cancers, including pancreatic ductal adenocarcinoma (Miyamoto et al., 2003) , mammary cancers in mice (Jhappan et al., 1992) , acute T-cell lymphoblastic leukemia (Ellisen et al., 1991) , Hodgkin's and anaplastic large cell lymphoma (Jundt et al., 2002) as well as cervical cancer (Zagouras et al., 1995) . These Figure 4 Immunohistochemical validation of five genes overexpressed in MCNs. Shown are representative tissue sections including H&E labeled in (a) and positive expression for PSCA (b), Jagged (c), HES1 (d), Frizzled (e) and L1CAM (f). HES1 labeling was performed on frozen sections of pancreatic tissue. Immunohistochemistry of the remaining genes was carried out on sections of formalin-fixed paraffin-embedded tissue microarrays. The inset of (f) shows strong positive staining of a peripheral nerve tissue as a control Gene expression profile in MCNs N Fukushima et al studies implicate Notch pathway activation as oncogenic. However, in certain cell types, notch activation is tumor suppressive. For example, loss of Notch leads to sustained overexpression of Gli2 in the skin, promoting tumor development (Nicolas et al., 2003) . Hes1 is also overexpressed in early PanINs, suggesting that it may contribute to early pancreatic neoplastic development (Miyamoto et al., 2003) . Other investigators have observed overexpression of the Notch4 ligand in pancreatic ductal adenocarcinomas . The finding of overexpression of members of the Notch pathway in MCNs suggests that this pathway is important in MCN development.
STK15 (STK6/aurora-A) is a novel serine threonine kinase that is overexpressed in multiple tumor types. Stk6 is located on an amplicon frequently amplified and overexpressed in breast (Hodgson et al., 2003) , pancreatic (Mahlamaki et al., 2002; Li et al., 2003) and other cancers. A polymorphism in STK6 identified as a modifier of cancer risk in mice led to investigations demonstrating that the same 91A variant was associated with an increased risk of developing colon cancer and tumors were much more likely to amplify the 91A variant than the normal allele (Ewart-Toland et al., 2003) . The 91A variant has also been shown to increase the risk of developing esophageal cancer (Miao et al., 2004) . Overexpression of STK15 occurs in many tumors without evidence of gene amplification (Hodgson et al., 2003) . Importantly, STK15 inhibitors show considerable promise as anticancer agents in preclinical models (Sausville, 2004) .
The 'ovarian-type' stroma of MCNs is composed of densely packed spindle cells expressing a smooth muscle phenotype, along with estrogen and/or progesterone receptors (Fukushima and Mukai, 1997; Zamboni et al., 1999) . This stroma exhibits a variable degree of luteinization characterized by presence of epithelioid cells with round to oval nuclei and abundant clear or eosinophilic cytoplasm, and these cells are known to express calretinin and alpha-inhibin (Zamboni et al., 1999) . The genes overexpressed in 'ovarian-type' stroma included sex hormone-related genes such as STAR and ESR1. The STAR protein, by enhancing the metabolism of cholesterol into pregnenolone, has a key role in steroid hormone synthesis, and is responsible for the transfer of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane where it is cleaved to pregnenolone (Sorianello et al., 2002) . In the normal ovary, STAR is expressed in luteinized follicles and in theca cells (Sorianello et al., 2002) . We observed overexpression of STAR transcript in 'ovarian-type' stroma, although other genes involved in progesterone and androgen biosynthesis were expressed at low levels. This pattern is similar to that seen in the postmenopausal ovary (Jabara et al., 2003) . Another gene identified as overexpressed in ovarian stroma was the secreted Fizzled-related protein (sFRP) known for its function as a modulator of Wnt signaling. The Wnt pathway influences many biological processes such as cell polarity, adhesion, tumorigenesis and apoptosis (Jones and Jomary, 2002). Several reports have described the relationship between sFRP expression and high estrogen status; sFRP expression in human uterine leiomyomas correlates with estrogen level (Fukuhara et al., 2002) , and sFRP and estrogen receptor-alpha transcripts colocalize in decidual cells during pregnancy (Ernst et al., 2002) . Other genes known to be estrogen induced in the setting of breast cancer or in normal breast epithelium were not overexpressed in MCNs (data not shown) (Seth et al., 2002; Frasor et al., 2003) . The availability of frozen ovarian stroma tissue from additional patients with MCNs would permit comparison of this tissue with normal ovary to identify further similarities as well as differences between these tissue types. Such a comparison could identify genes mediating the growth and maintenance of ovarian stroma in MCNs. Overall, the finding of genes implicated in female genital organ function suggests that the almost exclusive female predominance of MCNs could result from the sensitivity of MCNs to female hormones.
The L1CAM is a membrane glycoprotein of the immunoglobulin family and has an important function in development of the nervous system by regulating cell adhesion and migration (Schachner, 1997; Kamiguchi et al., 1998) . However, L1CAM expression is seen not only in nervous tissues but has also been detected in lymphocytes, granulocytes, epithelial cells of the intestinal and urogenital tract, and in the epidermis (Thor et al., 1987; Kowitz et al., 1992; Kalus et al., 2003) . L1CAM expression has also been detected in several highly malignant tumors (Deichmann et al., 2003; Fogel et al., 2003a, b) . We confirmed the characteristic membranous staining pattern in ovarian-type stroma in two of 14 cases by immunohistochemistry.
In the clinical setting, it remains difficult to distinguish neoplastic from non-neoplastic pancreatic cysts either by radiological, endoscopic or biochemical means. Previous attempts to differentiate neoplastic from nonneoplastic cysts include analysis of aspirated cyst fluid for cytology, enzymes and tumor markers (Rubin et al., 1994; Hammel et al., 1995; Sand et al., 1996; Sperti et al., 1996 Sperti et al., , 1997 . Thus, there is a need for a panel of markers that can accurately differentiate neoplastic from nonneoplastic pancreatic cysts. Our list of overexpressed genes in MCNs can be used in future studies whose aim is to determine the diagnostic utility of markers detected at the RNA or protein level in needle aspirates of pancreatic cysts.
In conclusion, we have identified several genes that are overexpressed in MCNs that indicate alterations in several important biochemical pathways. Knowledge of the gene expression profiles of MCNs may be useful in the differential diagnosis of these lesions in the clinical setting.
Materials and methods
Patients and specimens
Fresh frozen tissues from pancreatic resections containing MCNs were obtained from the tumor bank of the Department of Pathology from eight patients (all women, 23-57 years, mean 43.3 years) who underwent distal pancreatectomy at the Johns Hopkins Hospital between the years 1989 and 2000 (Table 1 ). The MCNs had been stored at À701C since their resection with the approval of the Johns Hopkins Committee for Clinical Investigation. The diagnosis of MCN was based on WHO criteria: a cystic epithelial neoplasm that lacked communication with the pancreatic duct system and that is composed of columnar, mucinproducing epithelium, supported by ovarian-type stroma (Zamboni et al., 2000) . The eight MCNs included five adenomas, two borderline neoplasms and one in situ adenocarcinoma.
To obtain histologically normal pancreatic ductal epithelium and acinar cells for comparison, eight normal pancreatic frozen tissues were collected from histologically normalappearing pancreata. The pancreatic ductal epithelia were dissected from larger interlobular ducts. Five pancreata were resected from patients with pancreatic ductal adenocarcinoma, two were from patients with chronic pancreatitis and one was from a patient with an MCN (49-72 years, mean 62.4 years). As a control for the analysis in 'ovariantype' stroma, fibrous stromal cells without marked inflammatory cell aggregate were microdissected from the surgical resection specimens of three patients with chronic pancreatitis (19-72 years, mean 49 years). Fibroblast cells were also obtained from the surgical resection specimens of a 33-year-old male patient with chronic pancreatitis and grown in vitro at low passage (a gift from Dr Masao Tanaka and Dr Kazuhiro Mizumoto, Kyushu University, Fukuoka, Japan). These culture cells were used as a control for the quantitative RT-PCR analysis.
Laser capture microdissection
Frozen tissue sections (8 mm) were cut and the slides were stored immediately at À701C until subsequent fixation. Every second section was labeled with hematoxylin and eosin (H&E) and covered with a glass coverslip for diagnostic purposes. Tissue sections that underwent LCM were defrosted, fixed (70% ethanol for 3 min) and dehydrated (100% ethanol for 3 min, xylene for 5 min). Sections were dissected using a Pixcell II LCM system (Arcturus Engineering Inc., Mountain View, CA, USA) with a 7.5 mm diameter laser beam (Figure 1) . Generally, cells were obtained from 10-20 sections by LCM in order to have sufficient numbers of cells for subsequent RNA amplification.
RNA extraction and amplification
Total RNA was extracted from microdissected tissue using the Picopure RNA isolation kit (Arcturus) according to the manufacturer's instructions. After determining RNA quality using RT-PCR amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the extracted RNA was subjected to two rounds of linear amplification using the RiboAmp RNA amplification kit (Arcturus). During the second round of amplification, the Enzo s BioArray (tm) HighYield (tm) RNA Transcript Labeling Kit was used to label the RNA during the in vitro transcription (IVT) step (Enzo Diagnostics Inc., Farmingdale, NY, USA). If after IVT the RNA yield was not sufficient for hybridization (>15 mg), additional cells were laser capture microdissected from the same neoplasm and the RNA extraction and two rounds of amplification process were repeated until sufficient RNA was obtained for oligonucleotide microarray analysis.
Oligonucleotide array hybridization and data analysis
A 15 mg of total RNA was used for array hybridization as per the manufacturer's protocol. The fragmented cRNA was hybridized to the Human Genome U133A chips (Affymetrix, Santa Clara, CA, USA) with 18 462 genes/EST transcripts at 451C for 16 h. The washing and labeling procedures were performed using the Affymetrix Fluidics Station according to the manufacturer's instructions. The arrays were then scanned using a Gene Array Scanner (Agilent, Palo Alto, CA, USA), and signal intensity for each transcript (background-subtracted and adjusted for noise) was determined using Microarray Suite Software 5.0 (Affymetrix).
One-step SYBR Green -based quantitative RT-PCR
To confirm gene expression differences identified by microarray data, 10 genes were selected from the GeneChip list of overexpressed genes. One-step SYBR Green-based RT-PCR amplification was performed using an ABI7700 thermocycler (Applied Biosystems, Foster City, CA, USA). After optimization of each of the primer pairs, samples were assayed in a 50-ml reaction mixture containing 2 ml of sample RNA and optimal concentration of each of the primers by using the QuantiTect SYBR Green RT-PCR kit (Qiagen, Valencia, CA, USA). The primer sequences are shown in Table 2 . The thermal profile for one-step SYBR Green-based RT-PCR consisted of a 30-min RT step at 501C and 15 min of Taq polymerase activation at 951C, followed by 43 cycles of PCR at 951C for 20 s (denaturation), 581C for 30 s (annealing) and 721C for 30 s (extension).
Tissue microarrays
To further confirm the gene expression patterns identified by Affymetrix gene expression profiling, we determined the tissue protein expression patterns overexpressed in genes in an independent series of MCNs. Formalin-fixed paraffin-embedded blocks of a series of MCNs were obtained from the surgical pathology archives of the Department of Pathology at the Johns Hopkins Hospital. The MCN TMAs contained 76 microcores from 19 MCN resection specimens. For the TMA construction, representative areas containing morphologically defined MCNs were circled on the glass slides and used as a template. TMAs were constructed using a manual Tissue Puncher/Arrayer (Beecher Instruments, Silver Spring, MD, USA). The diameter of the punched core was 1.4 mm. Serial sections were cut from these TMAs, of which one was labeled with H&E as a reference.
Immunohistochemistry
TMA sections (4 mm) mounted on positively charged slides were incubated for 30 min and deparaffinized by standardized methods. Antigen retrieval was performed for 20 min, in 10 mM sodium citrate buffer (pH 6.0) heated at 951C in a steamer, followed by cooling off for 20 min. After blocking endogenous peroxidase activity with a 3% aqueous H 2 O 2 solution for 5 min, the primary antibodies were incubated with the sections at each final concentration for 60 min in a Dako automatic immunostainer (Dako, Carpinteria, CA, USA). The same 8 mm frozen sections that were used to microdissect the MCNs were stained with the HES1 antibody using similar methods outlined above with the exception that the Hes1 antibody did not require an antigen retrieval step. The primary antibodies used for immunohistochemistry were a rabbit polyclonal antibody against fizzled-related protein (H-300, Santa Cruz Biotechnology, Santa Cruz, CA, USA, dilution 1 : 25), Jagged (H-66, Santa Cruz, 1 : 100) and a mouse monoclonal antibody against the L1 cell adhesion molecule (L1CAM, UJ127, Lab Vision, Fremont, CA, USA, 1 : 100). Antibodies against prostate stem cell antigen (PSCA, clone 1G8, 1 : 200) and HES1 (1 : 100) were kindly provided by Dr Robert E Reiter, Department of Urology, University of California and Dr Tetsuo Sudo, Toray Industries Inc., respectively. For every TMA slide labeled, a control slide was incubated, with Tris-buffered saline buffer substituted for the primary antibody. The EnVision þ DAB þ detection kit (Dako, Carpinteria, CA, USA) was used for the detection of immunolabeling. Sections were counterstained with hematoxylin. Before immunohistochemical evaluation, each MCN core arrayed on the TMA was graded into adenoma, borderline and carcinoma lesions using the H&E-stained slide. Immunolabeling patterns were scored as either positive (positive labeling in >10% of neoplastic cells) or negative. Immunohistochemical labeling was considered positive if at least one of the tissue cores from the case showed positive immunostaining.
Data analysis
The Affymetrix Data Mining Tool software was used to compare the gene expression profiles of signal intensity of each group. Gene expression differences of at least threefold (fold change) between neoplastic epithelium and normal ductal epithelium were considered significant. For the comparison of ovarian-type stroma with the fibrous stroma of chronic pancreatitis, differences of at least fivefold were considered significant. Gene expression analysis using real-time, quantitative PCR data utilized the 2 ÀDDCT method (Livak and Schmittgen, 2001).
